Primary objectives
To assess 2-year overall survival in each treatment arm
Detailed description · Outline
Treatment repeats every 28 days for 3 courses in the absence of disease progression or unacceptable toxicity. Patients achieving stable disease or better undergo pancreatectomy 4-8 weeks after completion of first 3 courses of treatment. … patients are followed up every 3 months for 2 years and then every 6 months for 2 years.
Secondary objectives
frequency and severity of adverse events associated with chemotherapy in the perioperative setting. … overall response rate following preoperative chemotherapy … per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
Outcome measures
within 4 to 8 weeks after the last dose of Cycle 3 preoperative chemotherapy … R0 resection classification is defined as macroscopically complete tumor removal with negative microscopic surgical margins